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Background/Aims: We aimed to determine the association between the co-expression patterns of Notch1, Snail, and p53 
proteins (NSP) and the postoperative prognosis of hepatocellular carcinoma (HCC). Methods: The immunoblot data for 
molecular expression (147 HCC/corresponding non-HCC tissues and 15 dysplastic nodules) and the sequencing data for 
p53 mutations (110 HCCs) were obtained from our previous study. Data analyses were restricted to cases with HCC 
differentiation grade III (n=47), due to its high p53 mutation rate.  Results: Nineteen of the 47 patients (40.4%) 
-comprising 12 in the liver and 7 in distant organs-had relapsed at 1-2 years after surgery. There was no relationship 
between p53 mutation and postoperative recurrence in the grade III HCCs. Seven (87.5%) of the eight relapsed cases 
with Notch1, Snail, and p53 (wild) co-expression experienced recurrence only within the liver, and all tumors were smaller 
than 5 cm in diameter. Extrahepatic relapse occurred mostly in HCC patients with tumors larger than 5 cm in diameter, 
without any deviation in the NSP pattern. Conclusions: The results of this preliminary study suggest that the 
co-expression of Notch1, Snail, and p53 (wild) is not inferior to the patterns with p53 mutation as an indicator of 
postoperative recurrence of grade III HCC. (Korean J Hepatol 2012;18:63-74)
Keywords: Notch1 intracellular domain; p53; Snail; p53 mutation; Hepatocellular carcinoma
Received October 28, 2011; Revised January 18, 2012; Accepted January 20, 2012
Abbreviations: DFI, disease-free interval; DN, dysplastic nodule; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; NICD, Notch1 intracellular
domain; p53Mut, p53 mutation; p53WT, p53 wild type
*Co-corresponding author: 
Young Min Park
Hepatology Center, Bundang Jesaeng General Hospital, Seongnam 463-774, Korea
Tel. +82-31-779-0676, Fax. +82-31-779-0164, E-mail; ymp1@hotmail.com
Guhung Jung
Department of Biological Sciences, Seoul National University, 599 Gwanak-ro, Gwanak-gu, Seoul 151-747, Korea
Tel. +82-2-880-7773, Fax. +82-2-872-1993, Email: drjung@snu.ac.kr
Copyright Ⓒ  2012 by The Korean Association for the Study of the Liver
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) 
which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
INTRODUCTION
Hepatocellular carcinoma (HCC), one of the most common 
malignant tumors worldwide,
1 is usually treated by surgical 
resection, particularly in patients with American Joint 
Committee on Cancer (AJCC)-TNM stages I or II and 
reserved liver function.
2 Because postoperative recurrence is 
the main obstacle to the success of this aggressive trea-
tment,
3,4 various pathological features of surgical specimens 
have been established as predictors of risk of recurrence. 
They include tumor size and number, microvascular 
invasion, portal vein tumor thrombosis, the presence of 
satellite nodules, differentiation grade of the tumor cells, and 
the encapsulation state.
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cm), multiplicity, a cut margin narrower than 1 cm, and 
tumor stage (including vascular invasion) are independent 
factors associated with early (within 2 years) recurrence 
after surgical resection.
3,4 The preoperative hepatic functional 
reserve and microscopic vascular invasion can enhance 
early recurrence of small HCCs.
7 Early multinodular 
recurrence after surgical resection is not unusual in HCCs 
with multiple tumor nodules and portal vein thrombi.
3 
Furthermore, late recurrence (>2 years after resection) is 
significantly associated with Ishak hepatic inflammatory 
activity >6; indocyanine green (ICG) retention rate at 15 min 
(ICG-15) >10%; and hepatitis B virus (HBV) DNA level 
>10
6 copies/mL.
4 Alpha-fetoprotein (AFP) and Lens culinaris 
agglutinin-reactive AFP (AFP-L3) are serological biomarkers 
of HCC with a more malignant nature.
6
Multiple intrahepatic or extrahepatic metastases are asso-
ciated with poor prognosis after recurrence.
8 Reportedly, 
the proportions of intra- and extrahepatic recurrences of 
HCC following surgery are 80% and 20%, respectively.
9 In 
brief, the organs involved in extrahepatic recurrence are 
lung (10.4-12.6%), adrenal glands (11%), peritoneum (6%), 
pancreas (3%), bone (1.5%), and brain (1.5%).
9-11
Given the increasing chances of earlier diagnosis by an 
HCC screening program for high-risk individuals selected 
from patients with chronic liver diseases, it is critical to 
identify the characteristic patterns of molecules that are 
associated with HCC recurrence and the preferred organ 
sites of relapse after surgical treatment. Candidate molecules 
associated with prognosis or risk of recurrence include 
osteopontin
9 and stathmin
12 in relation with intrahepatic 
recurrence of HCCs, the acquisition of p53 mutation 
(p53Mut) as a poor prognostic molecular marker,
13 and loss 
of E-cadherin with causal relationship to the invasiveness of 
HCC.
14
In our previous study, we have suggested that an 
orchestration of multiple molecules engage in the regulation 
of malignant cancer cell behaviors such as invasion and 
proliferation.
15 Further, we arbitrarily defined the co-expression 
patterns of Notch1, Snail, and p53 (NSP) proteins based on 
immunoblot analysis of clinical samples and matched them 
with experimentally observed malignant behavior.
15 We 
proved that the expression status of the wild type of p53 
(p53WT)/p53Mut interactively regulated Notch1 expression, 
and simultaneous upregulation of p53WT together with 
Notch1 and Snail expressions represented the invasive 
nature of HCCs.
15 In this study, we verified the clinical 
utility of the NSP pattern as postoperative prognostic 
molecular markers for HCC. Because most of the p53 
mutations occurred in grade III HCCs, data analyses were 
restricted to grade III HCCs to compare the effects of NSP 
patterns on the prognosis of HCC patients with p53WT and 
p53Mut.
MATERIALS AND METHODS
Inclusion of patients with immunoblot data for 
Notch1, Snail, and p53 and data for p53 mutations 
in HCCs
For this study, we obtained 162 immunoblots for the 
expression of Notch1, Snail, and p53 proteins and 110 
sequences for p53 mutations in HCCs. All experiments were 
performed as described in the previous study.
15 Briefly, 
rabbit monoclonal anti-Notch1 (diluted 1:100, Cell Signaling, 
Danvers, MA), rabbit polyclonal anti-Snail (diluted 1:100, 
Abcam, Cambridge, MA), and mouse monoclonal anti-p53 
(diluted 1:100, Santa Cruz Biotechnology) antibodies were 
used to detect each protein in paraffin sections, and 
automated sequencing was performed to detect p53 
mutations in frozen tissues (Appendix Fig. 1). Of the 162 
immunoblots obtained, 147 were from patients with HCC 
(33 grade I, 40 grade II, and 74 grade III); their corres-
ponding non-HCCs and 15 dysplastic nodules (DN) were 
used as controls. All tissue specimens, along with 
clinicopathological information, were obtained from 
Severance Hospital, Yonsei University College of 
Medicine (Seoul, Korea). The analyses focused on the 
effects of differentiation grade III HCC on postoperative 
prognosis, for which 47 cases were chosen on the basis of 
well-defined clinical records (mean age, 53±13 years; range, 
28-76 years; 38 men and 9 women). Together with 
biochemical liver function, HBV viral markers, and serum 
AFP and protein induced by vitamin K absence (PIVKA) 
tests, all patients underwent a liver spiral computed 
tomography (CT) scan every 3-6 months to detect recurrent 
HCC after surgery. All patients had HBV infection and 
reserved liver function (Child-Pugh A). The reason for 
this selection criterion was that the differentiation grade
4,5 
and poor liver function
7 themselves influenced the 
postoperative prognosis, and etiological factors could 
influence molecular expression patterns.
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Table 1. Characteristic pathological and molecular features of grade III HCC in comparison with those of grades I and II
　
Differentiation grades
Sum (%)　 P-value
*
I (n=33) II (n=40) III (n=74)
Pathological features
  Size (mean±SD, cm)      27.8±9.6      42.4±20.1      5 6 . 6 ± 2 3 . 1 <0.001
  Capsular formation 11 (33.3%) 17 (42.5%) 58 (78.4%) 86 (58.5%) <0.001
  Capsular infiltration
† 1 (9.1%) 7( 4 1 . 2 % ) 24 (41.4%) 32 (21.8%) 0.081
  Microvascular invasion 3 (9.1%) 28 (70.0%) 65 (87.8%) 96 (65.3%) <0.001
  Portal vein invasion 0 (-) 4( 1 0 . 0 % ) 14 (18.9%) 18 (12.2%) 0.004
  Satellite nodules 0 (-) 7 (17.5%) 22 (29.7%) 29 (19.7%) <0.001
Molecular features
  Notch1 up-regulation 15 (45.5%) 17 (42.5%) 37 (50.0%) 69 (46.9%) 0.574
  Snail up-regulation 12 (36.4%) 17 (42.5%) 47 (63.5%) 76 (51.7%) 0.004
  p53 total up-regulation 12 (36.4%) 20 (50.0%) 53 (71.6%) 85 (57.8%) <0.001
  p53 mutation
‡ 2( 1 0 . 0 % ) 4( 1 9 . 0 % ) 21 (35.0%) 27 (18.4%) 0.004
*Relationship between differentiation grade and each risk factor was analyzed by both chi-square test and Spearman's correlation test; 
†Analysis of capsular infiltration among HCCs with fibrous capsule formation surrounding tumor nodule, 
‡ Data about p53 mutations 
were available in 110 of the 147 HCC samples (Appendix Table 2).
Figure 1. Comparison of the maximum diameters of 162 tumor 
specimens (mean±SD, cm). DN: dysplastic nodule (n=15); G-1, 
differentiation grade I (n=33); G-2, differentiation grade II 
(n=40); G-3, differentiation grade III (n=74).
evaluation, we kept a routine histological examination data 
file on differentiation grades, tumor size, tumor capsule 
formation (encapsulation), capsular infiltration, microvascular 
invasion, portal vein invasion, and satellite nodules. 
Differentiation was graded according to Edmondson and 
Steiner’s criteria.
18 Informed consent was obtained from 
each patient, and tissue collection was approved by the 
Institutional Review Board.
Statistical analysis
Statistical analysis was performed using R statistics 
software (Ver.2.12.2.; The R Foundation for Statistical 
Computing, Vienna, Austria), which is a free software used 
under the terms of the Free Software Foundation’s GNU 
General Public License in source code form.
19 The 
relationship between the expression of several proteins and 
the HCC grade was analyzed by calculating Spearman’s 
correlation and by Fisher’s exact test for count. Logistic 
regression analysis and a chi-square test were done to 
analyze the significance of the relationships among the 
expression patterns of the molecules. P-values of less than 
0.05 were considered statistically significant.
RESULTS
Association of grade III HCC with pathological 
features indicating the risk of postoperative 
recurrence 
Because HCCs are classified on the basis of cellular 
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Table 2. Summary of the distribution of p53 mutations, recurrence frequencies, and relapse sites according to the NSP pattern in 
grade III HCC
NSP
I II
III (n=3)
A1 (n=15) A2 (n=5) B1 (n=3) B2 (n=0) A1 (n=7) A2 (n=3) B (n=11)
Notch1 ↑↑↑↑ ↔ ↔ ↔ ↔
Snail ↑ ↑ ↔ ↔ ↑ ↑ ↔ ↔
p53 ↑↔↑↔ ↑ ↔ ↑ ↔
p53 mutations
* (16/44) 3 0 1/2
* -5 0 / 1
* 70
Recurrence
†
  N o  ( n = 2 8 ) 7 4 1- 429 1
  Yes (n=19) 8 1 2 - 3 1 2 2
Size (mean±SD, mm)
  Recurrence (-) 56±33 45±23 49±24 38±28 35±16 31±15 38±19 39±22
  Recurrence (+) 48±22 44±20 60±40 - 60±19 59±33 55±19 60±90
  ( P-value) >0.05
‡ >0.05
‡ >0.05
‡ - 0.0133
‡ >0.05
‡ 0.0265
‡ 0.0181
‡
Intra-hepatic (n=12) 7 1 1 - 1 1 1 -
Extra-hepatic (n=7) 1 - 1 - 2 - 1 2
*Data was not available in three cases (P=0.04); 
†Intra-or extra-hepatic recurrence; 
‡No significant difference in size between recurrent 
HCCs with IA1 and with IIB (P=0.3545).
↑, overexpression greater than a 2-fold increase; ↔, no overexpression; ‘-’, there are no cases in those patterns.
malignant nature of HCC. Therefore, in comparison with 
grades I and II HCCs, we characterized grade III HCC in 
view of their relationship with other pathological features 
that directly indicated postoperative prognosis, such as 
tumor size, encapsulation status, capsular infiltration, 
microvascular invasion, portal vein thrombosis, and satellite 
nodules. As summarized in Table 1 and Figure 1, the 
correlation between differentiation grades and other 
pathological features suggests that grade III HCC was more 
malignant than grade I and/or II HCCs.
Characteristic changes of both individual and 
co-expression statuses of Notch1, Snail, and p53 
proteins in grade III HCC
Of the 3 core molecules Notch1, Snail, and p53 proteins, 
which are components of the NSP pattern, the expression of 
Snail and p53 proteins were more significantly upregulated 
in grade III HCC than in grade I or II HCCs (P<0.01 and 
P<0.001, respectively), whereas Notch1 expression was not 
(P>0.1) (Table 1). Of the 8 NSP patterns, the proportional 
rates of NSP-IA1 (Notch1↑/Snail↑/p53↑), NSP-IIA1 
(Notch1↔/Snail↑/p53↑), and NSP-IIB (Notch1↔/Snail↔
/p53↑) patterns increased according to the differentiation 
grade; the NSP-IA2 (Notch1↑/Snail↑/p53↔) pattern was 
stationary; and the NSP-III pattern decreased (Appendix 
Table 1). This observation strongly suggests that the co- 
expression of these 3 core molecules may be regulated 
differently according to the differentiation grade of HCC. 
Association of the p53 mutation rate with NSP 
patterns according to differentiation grades
In our previous study, we demonstrated that both the 
expression level and the mutation of p53 protein were key 
factors regulating the nature of co-expression of the 3 core 
molecules selected for this study.
15 Although there was a 
positive correlation between differentiation grade and the 
total incidence of p53 upregulation by immunoblot analysis, 
the incidence of upregulation of wild-type p53 was not 
altered in the various differentiation grades, whereas the 
majority of p53 mutations occurred in grade III HCC (Table 
1 and Appendix Table 2).
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Table 3. Comparison of clinicopathological and molecular features between grade III HCCs with and without recurrence
　
HCCs with differentiation grade III
Significance
Recurrence Non-recurrence
Number of cases 19 (41.7%) 28 (58.3%)
Age (mean±SD) 53±13 55±10 0.610 
Sex (M/F) 17/2 21/7 0.202 
HCC serological biomarker
  Alpha-fetoprotein (ng/mL) 7441±20474 2669±8241 0.130 
  PIVKA-II (AU/mL) 800±902 522±742 0.531 
Pathological features
  Size (max. cm, mean±SD) 51.4±20.9 54.5±22.9 0.629 
  Fibrous encapsulation  18/19 (94.7%) 21/28 (75.0%) 0.080 
  Capsular infiltration  8/18 (44.4%) 6/21 (28.6%) 0.316 
  Microvascular invasion  16/19 (84.2%) 26/28 (92.9%) 0.356 
  Portal vein invasion  8/19 (42.1%) 2/28 (7.1%) 0.003
*
  Satellite nodules  6/19 (31.6%) 6/28 (21.4%) 0.445 
Molecular expressions
  N o t c h 1  ↑ 11/19 (57.9%) 12/28 (42.9%) 0.446 
  Snail ↑ 13/19 (68.4%) 17/28 (60.7%) 0.921 
  p53 total ↑ 15/19 (78.9%) 21/28 (75.0%) 0.719 
  p53 mutant
† 6/18 (33.3%) 10/26 (38.5%) 0.215 
*Only the portal vein invasion was statistically significant in both univariate and multivariate analyses, but other pathological risk 
factors were not significant, 
†Data was not available in three cases.
↑, overexpression greater than a 2-fold increase; Male-to-female ratios of total, recurrent and non-recurrent cases are 4.2:1, 8.5:1 and 
3:1, respectively.
upregulation rate was 36.3% (16/47), but the majority of the 
p53 mutations (75%, 12/16) were found in the NSP-II 
category. The distribution of p53 mutation rates differed 
significantly according to the NSP pattern: 71.4% (5/7) 
occurred in NSP-IIA1 and 63.6% (7/11) in NSP-IIB, whereas 
20% (3/15) occurred in NSP-IA1 (P<0.001) (Table 2). The 
p53 mutation rate was different between the NSP-I and 
NSP-II categories.
Association of pathological features with NSP 
patterns according to differentiation grades
Of the pathological features associated with differentiation 
grades, tumor size, microvascular invasion, portal vein 
invasion, and satellite nodules did not differ according to the 
NSP pattern (Appendix Table 3 and 4). Interestingly, the 
NSP-IIB pattern (Notch1↔/Snail↔/p53↑) showed a drastic 
increase in the incidence of fibrous capsule formation in 
grade III HCC than in grade II HCC (93.8% (15/16) vs. 
12.5% (1/8), respectively) (Appendix Table 5). Furthermore, 
both NSP-IA1 (Notch1↑/Snail↑/p53↑) and NSP-IIB patterns 
showed significant trends of capsular infiltration, compared 
to the NSP-IA2 (Notch1↑/Snail↑/p53↔) pattern with 
incidences of 50% (8/18), 53.3% (8/15), and 0% (0/6), 
respectively (P=0.002 and P=0.004, respectively) (Appendix 
Table 5).
Characteristic pathological features related to 
postoperative recurrence of grade III HCC
On the basis of the data of pathological and molecular 
characterizations related to grade III HCC described above, 
we focused our analysis on how grade III HCC might affect 
postoperative recurrence. Of the 47 grade III HCC patients, 
19 (41.7%) relapsed 8.6±5.9 months after surgical resection 
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Table 4. Comparison of the clinicopathological and molecular features between grade III HCCs with intrahepatic and with 
extrahepatic recurrences
HCCs with differentiation grade III
Significance
Intra-hepatic recurrence Extra-hepatic recurrence
N u m b e r  o f  c a s e s 1 2( 6 3 . 2 % ) 7( 3 6 . 8 % )
Age (Mean±SD) 53±11 54±18
Sex (M/F) 11/1 6/1
DFI (mon, mean±SD) 8.8±5.8 8.4±6.4
Pathological features
Size (max. cm, mean±SD) 40.5±17.3 70.0±10.8 0.002
*
Fibrous encapsulation  12/12 (100%) 6/7 (85.7%) 0.148 
Capsular infiltration  6/12 (50.0%) 2/6 (33.3%) 0.499 
Microvascular invasion  11/12 (91.7%) 5/7 (71.4%) 0.252 
Portal vein invasion  5/12 (41.7%) 3/7 (42.9%) 0.960 
Satellite nodules  4/12 (33.3%) 2/7 (28.6%) 0.829 
Molecular expressions
Notch1  ↑ 9/12 (75%) 2/7 (28.6%) 0.035
*
Snail  ↑ 10/12 (83.3%) 3/7 (42.9%) 0.017
*
p53 total ↑ 10/12 (83.3%) 5/7 (71.4%) 0.453 
p53 mutant
† 3/11 (27.3%) 3/7 (42.9%) 0.381 
*Tumor size, Notch1 and Snail expression states were significantly associated with relapse sites, but p53 states and other pathological 
risk factors except for tumor size were not significant, 
†Data was not available in three cases. 
↑, overexpression greater than a 2-fold increase; DFI, disease-free interval. 
differences in clinical variables, including age, sex, and 
preoperative serum AFP and PIVKA-II levels between the 
recurrent and non-recurrent groups (Table 3). In this cohort, 
only portal vein invasion was significantly correlated with 
recurrence (P=0.003): 42.1% (8/19) in the recurrence and 
7.1% (2/28) in the non-recurrence groups (Table 3). These 
data suggest that, when limited to grade III HCC, portal vein 
invasion is the most important pathological feature for 
predicting the risk of postoperative recurrence. 
Association of the NSP pattern with postoperative 
recurrence in grade III HCC
The individual expression status of Notch1, Snail, and 
p53 proteins was not associated with recurrence. Moreover, 
p53 mutation was not a significant prognostic factor for 
postoperative recurrence when the analysis was restricted 
to the grade III HCC group (Table 3). In addition, the 
recurrence rates of the NSP-IA1 (Notch1↑/Snail↑/p53↑) 
with p53 wild dominant and NSP-IIB (Notch1↔/Snail↔
/p53↑) with p53 mutant dominant were 53.3% (8/15) and 
18.2% (2/11), respectively (P=0.1092) (Table 2). 
In HCCs with the NSP-I pattern, the mean tumor size was 
not significantly different between the recurrence and 
non-recurrence groups (smaller than 5 cm in both groups). 
However, in HCCs with the NSP-IIA1 and NSP-IIB 
patterns, the mean tumor size was significantly larger in the 
recurrence group than in the non-recurrence group (Table 2). 
Other pathological prognostic features were not significantly 
different between the recurrence and non-recurrence groups 
according to the NSP patterns. 
Characteristic pathological features associated 
with the relapse sites of grade III HCC 
Twelve of 19 cases (63.2%) recurred within the liver and 7 
(36.8%) recurred at extrahepatic sites, including 6 lung 
and 1 mediastinal lymph node metastases (Appendix Table 
1). Two of 6 cases of pulmonary recurrence were 
accompanied by metastasis in other sites: 1 in the brain and 1 
in an abdominal lymph node. There were no significant 
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recurrence groups in clinical parameters, including age, sex, 
and DFI (Table 4). 
Among the pathological prognostic features, only tumor 
size was significantly associated with relapse sites (P= 
0.002): 40.5±17.3 cm in cases with intrahepatic recurrence 
and 70.0±10.8 cm in cases with extrahepatic recurrence 
(Table 4). The presence of microvascular tumor emboli, 
portal vein invasion, non-capsulation, or satellite nodules 
were not significant (Table 4). These data suggest that, of 
all clinicopathological parameters, only tumor size is 
important as an indicator for extrahepatic recurrence of 
grade III HCC and that the maximum cut-off size would 
be a diameter of 5 cm.
Association of the NSP pattern with postoperative 
relapse sites in grade III HCC
While the Notch1 and Snail proteins were not associated 
with the recurrence itself, the upregulation of Notch1 and 
Snail proteins were individually associated with the relapse 
sites (P=0.035 and P=0.017, respectively) (Table 4). In 
NSP pattern analysis, intrahepatic recurrence tended to be 
clustered in the NSP-IA1 pattern, while scattered in the 
non-NSP-IA1 patterns, although there was no statistical 
significance between both (87.5% [7/8] vs. 45.5% 5/11), 
respectively, P=0.1473). Extrahepatic recurrence rate of the 
NSP-IA1 and non-NSP-IA1 patterns was 12.5% (1/8) and 
54.5% (6/11), respectively (P=0.1473) (Table 2). There was 
no deviation of the NSP patterns in cases with extrahepatic 
recurrence. 
Although the NSP-IA1 pattern and tumor size showed 
potential as significant markers for indicating postoperative 
recurrence in grade III HCC, the Kaplan-Meier curve 
analysis showed no significant difference in the recurrence 
time based on NSP patterns (NSP-IA1 vs. non-IA1) and 
tumor size (cut-off diameter, 5 cm), as well as the relapse 
sites.
DISCUSSION
In this study, we focused primarily on the analyses of 
grade III HCC to clarify the association between NSP 
patterns and pathological malignant features indicating 
postoperative prognosis, including tumor size, fibrous 
encapsulation, capsular infiltration, microvascular invasion, 
portal vein invasion, and satellite nodules. The rationale for 
restricting the cases to the differentiation grade III is based 
on the observation that the majority of p53 mutations 
develop in grade III HCCs. Our data suggest that, even 
though the p53 is not mutated, the co-expression of three 
core molecules (Notch1↑/Snail↑/p53↑) in grade III HCC 
might be associated with postoperative recurrence risk, 
particularly in patients with HCC smaller than 5 cm in 
diameter, most of which fall within the best criteria for 
surgical treatment on the basis of AJCC-TNM staging.
Although p53 mutation was noticed as a prognostic 
marker of HCC,
13 our data suggested that, when the analyses 
was limited to grade III HCC, the p53 mutation is not the 
sole molecular marker for indicating the postoperative 
recurrence risk. Instead, it was suggested that HCC cases 
with the co-expression of Notch1, Snail and p53 (with wild 
dominant, NSP-IA1 pattern) is a preferred cluster for 
intrahepatic relapse. 
In accordance with conventional knowledge, our study 
also revealed that pathological prognostic features 
including tumor size, fibrous capsule formation, capsular 
infiltration, microvascular invasion, portal invasion, and 
satellite nodules, were well-correlated with differentiation 
grades of HCCs. These findings explain why grade III 
HCC is more malignant than grade I or II HCC, but do not 
address the following 2 concerns: the presence of any 
molecular type more prone to postoperative recurrence, and 
the nature of organ preference when relapse occurs.
When we focused on grade III HCC, our results revealed 
that only portal vein invasion was a significant pathologically 
independent prognostic factor for postoperative recurrence, 
whereas tumor size, encapsulation, capsular infiltration, 
microvascular invasion, and satellite nodules were not. 
However, the utility of portal vein invasion is limited 
because it occurs in only 18.9% of cases treated by surgical 
resection. Although microvascular invasion is an important 
predictor of postoperative recurrence, it was not a significant 
discriminating factor in grade III HCC because its rate of 
occurrence was 87.8%. Therefore, our results suggest that 
conventional pathological malignant features for predicting 
the postoperative recurrence risk are not useful in cases of 
grade III HCC. 
Fibrous capsule formation surrounding an HCC nodule 
has been reported as a good prognostic marker for surgical 
treatment,
5 and capsular infiltration by cancer cells as a poor 
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surgical resection.
5 Our study revealed that the prevalence of 
encapsulated tumors was positively correlated to the 
differentiation grade, and when compared to that of 
NSP-IA2 (Notch1↑/Snail↑/p53↔), capsular infiltration was 
significantly associated with the NSP-IA1 (Notch1↑/Snail↑
/p53↑) pattern. Therefore, in combination with activation of 
the Notch1-Snail signal axis, p53 upregulation may 
contribute to the acquisition of an invasive nature as 
suggested in our previous study.
15 
Therefore, with respect to grade III HCCs, it can be 
concluded that together with tumor size, only portal vein 
invasion is significant as a pathological prognostic factor to 
indicate postoperative recurrence, whereas microvascular 
invasion and satellite nodules are not. Likewise, p53 
mutation is not a significant molecular marker for indicating 
postoperative recurrence in grade III HCCs. The most 
significant marker for predicting extrahepatic recurrence is 
the tumor size larger than 5 cm in maximum diameter. 
Although the data is insufficient, our preliminary study 
focusing on the inter-relationships between pathological 
prognostic features and NSP patterns in grade III HCC may 
provide new insights into the role of molecular pattern 
analyses for predicting postoperative recurrence risk.
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Appendix Table 1. Comparison of proportional distribution rates of NSP patterns according to the differentiation grades of HCCs 
(n=162)
NSP
I II
III
A1 A2 B1 B2 A1 A2 B
Notch1 ↑↑↑↑ ↔ ↔ ↔ ↔
Snail ↑ ↑ ↔ ↔ ↑ ↑ ↔ ↔
p53 ↑↔↑↔ ↑ ↔ ↑↔
Dysplastic nodule (n=15) - 1 - - - 3 - 11
6.7% 20.0% 73.3%
Grade I (n=33) 3 5 3 5 2 2 4 9
9.1% 15.2% 9.1% 15.2% 6.1% 6.1% 12.1% 27.3%
Grade II (n=40) 5 7 3 2 4 1 8 10
12.5% 17.5% 7.5% 5.0% 10.0% 2.5% 20.0% 25.0%
Grade III (n=74) 22 10 4 1 11 4 16 6
29.7% 13.5% 5.4% 1.4% 14.9% 5.4% 21.6% 8.1%
↑, overexpression greater than a 2-fold increase; ↔, no overexpression; NSP patterns, Co-expression patterns of Notch1, Snail and 
p53 proteins; ‘-’, there are no cases in those patterns.
Appendix Table 2.
* Comparison of proportional distribution of NSP patterns in p53↑, p53W↑, and p53M according to the differentiation
grade
NSP
I II
III
A1 A2 B1 B2 A1 A2 B
Notch1 ↑↑↑↑ ↔ ↔ ↔ ↔
Snail ↑ ↑ ↔ ↔ ↑ ↑ ↔ ↔
p53 ↑↔↑↔ ↑ ↔ ↑ ↔
p53 mutations (n=110)
G-1 p53↑ 7/20 (35.0%) 2 - 3 - - - 2 -
p53W↑ 7/20 (35.0%) 2 - 3 - - - 2 -
p 5 3 M 0 / 2 0 ( 0 . 0 % ) ---- - - - -
G-2 p53↑ 18/30 (60.0%) 4 1 2 5 6
p53W↑ 14/30 (46.7%) 4 - 2 - 3 - 5 -
p53M 4/30 (13.3%) - 1 - - 2 - 1 -
G-3 p53↑ 46/60 (76.7%) 18 1 2 9 16
p53W↑ 25/60 (41.7%) 14 - 1 - 4 - 6 -
p53M 21/60 (35.0%) 4 1 1 - 5 - 10 -
*Data of this table cited from the supplementary tables in our previous study.
20
NSP patterns, Co-expression patterns of Notch1, Snail and p53 proteins; DN, dysplastic nodule; G-1, differentiation grade I; G-2, 
differentiation grade II; G-3, differentiation grade III; p53W, p53 wild type; p53M, p53 mutant type; ↑, overexpression greater than 
a 2-fold increase; ↔, no overexpression; p53↑, p53 overexpression by p53W or p53M; ‘-’ means the p53 expression was not 
detectable by immunoblot and all these were p53 wild type by automated sequencing method; p53W↑ rates were not different among 
differentiation grade; Both p53M↑ and total p53↑ rates were significantly higher in grade III HCCs; Two cases were p53 mutated 
but not overexpressed in each one of grade II and III HCCs.72  The Korean Journal of Hepatology Vol. 18. No. 1, March 2012
Appendix Table 3. Differences in changes in tumor size among the NSP patterns according to the HCC differentiation grades
NSP No. (mm, mean±SD)
I II
III 
A1 A2 B1 B2 A1 A2 B
Notch1 ↑↑↑↑ ↔ ↔ ↔↔
Snail ↑ ↑ ↔ ↔ ↑ ↑ ↔ ↔
p53 　 ↑↔↑↔ ↑↔↑ ↔
Grade 1  33 (26±10) 21±5 23±4 37±2 26±2 19±8 24±5 25±12 27±14
Grade 2 40 (43±21) 38±15  56±21  50±31  38±32 33±16 53 38±22 41±22
Grade 3 74 (56±23) 59±28  47±21  65±34 100 54±18 50±32 53±18 61±15
(P-value) <0.001
* 0.0043
* --- 0 . 0 0 6 3
* -0 . 0 0 6
* 0.0015
*
*P-value showing statistical significance.
↑, overexpression greater than a 2-fold increase; ↔, no overexpression; NSP patterns, co-expression patterns of Notch1, Snail and 
p53 proteins; Number of cases in each differentiation grade were 33 in grade I, 40 in grade II and 74 in grade III, respectively; 
‘-’, no cases or not statistically significant (P>0.1); Chi-square test with Yates’ continuity correction was used to compare the difference.
Appendix Table 4. Differences in the incidence of microvascular invasion, portal vein invasion, and satellite nodule formation among 
the NSP patterns according to the HCC differentiation grades
NSP No.
I II
III 
A1 A2 B1 B2 A1 A2 B
Notch1 ↑↑↑↑ ↔ ↔ ↔ ↔
Snail ↑ ↑ ↔ ↔ ↑ ↑ ↔ ↔
p53 　 ↑↔↑↔ ↑↔↑ ↔
Microvascular invasion
Grade 1 3/33 1/3 0/5 0/3 0/5 1/2 1/2 0/4 0/9
Grade 2 28/40 4/5 5/7 3/3 1/2 4/4 1/1 5/8 5/10
Grade 3 65/74 21/22 8/10 4/4 1/1 10/11 4/4 14/16 3/6
(P-value) <0.001
* 0.0079
* 0.0071
* 0.0021
* - - - 0.0013
* 0.0216
*
Portal vein invasion
Grade 1 0/11 - - - - - - - -
Grade 2 4/40 0/5 0/7 0/3 0/2 1/4 0/1 1/8 2/10
Grade 3 14/74 3/22 2/10 2/4 0/1 4/11 0/4 3.16 0/6
(P-value) 0.076
* - 0.097
* -- --- -
Satellite nodules　
G r a d e  1 0 / 1 1 ---- --- -
Grade 2 7/40 1/5 2/7 1/3 0/2 1/4 0/1 2/8 0/10
Grade 3 22/74 7/22 1/10 1/4 0/1 3/11 0/4 7/16 3/6
(P-value) 0.005
* - - - - - - 0.097
* 0.0079
*
*P-value showing statistical significance.
↑, overexpression greater than a 2-fold increase; ↔, no overexpression; NSP patterns, co-expression patterns of Notch1, Snail and 
p53 proteins; Number of cases in each differentiation grade were 33 in grade I, 40 in grade II and 74 in grade III, respectively; 
‘-’, no cases or not statistically significant (P>0.1); Chi-square test with Yates’ continuity correction was used to compare the 
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Appendix Table 5. Differences in encapsulation status among the NSP patterns according to the HCC differentiation grades
NSP No.
I II
III 
A1 A2 B1 B2 A1 A2 B
Notch1 ↑↑↑↑ ↔ ↔ ↔ ↔
Snail ↑ ↑ ↔ ↔ ↑ ↑ ↔ ↔
p53 　 ↑↔↑↔ ↑↔↑ ↔
Fibrous capsule 　
Grade 1 11/33 1/3 4/5 0/3 0/5 0/2 2/2 1/4 3/9
Grade 2 17/40 4/5 7/7 0/3 0/2 2/4 0/1 1/8 3/10
Grade 3 58/74 18/22 6/10 4/4 0/1 9/11 2/4 15/16
* 4/6
(P-value) 0.026
† ‐ ‐ 0.0003
† ‐ 0.0272
† ‐ 0.0002
† ‐
Capsular infiltration
Grade 1 1/11 ‐ ‐ ‐ ‐ ‐ ‐ 1/1 ‐
Grade 2 7/17 2/4 1/7 ‐‐2/2 ‐‐ 2/3
Grade 3 24/38 8/18 0/6 2/4 ‐ 3/9 2/2 8/15 1/4
(P-value) 0.569
† ‐‐‐‐ ‐‐‐ ‐
*Drastic increase in the incidence of fibrous capsule formation in grade III, when compared to that of grade I/II HCC, 
†P-value 
showing statistical significance.
↑, overexpression greater than a 2-fold increase; ↔, no overexpression; NSP patterns, co-expression patterns of Notch1, Snail and 
p53 proteins; Number of cases in each differentiation grade were 33 in grade I, 40 in grade II and 74 in grade III, respectively; 
‘-’, no cases or not statistically significant (P>0.1); Chi-square test with Yates’ continuity correction was used to compare the 
difference; The comparison in grade III between NSP-IA1 and NSP-IA2 was significant (P=0.002); The comparison in grade III 
between NSP-IIB and NSP-IA2 was significant (P=0.004).74  The Korean Journal of Hepatology Vol. 18. No. 1, March 2012
 
 
Appendix Figure 1. Representative examples of immunoblot analyses. (A) DN: dysplastic nodules, (B) G-1, differentiation grade I 
HCCs; (C) G-2, differentiation grade II HCCs; (D) G-3, differentiation grade III HCCs. T, HCC; NT, non-HCC; NICD, Notch1 
intracellular domain.